Phillip Bosua - Know Labs CEO Director
| KNW Stock | USD 0.24 0.01 4.35% |
Insider
Phillip Bosua is CEO Director of Know Labs
| Age | 50 |
| Address | 500 Union Street, Seattle, WA, United States, 98101 |
| Phone | 206 903 1351 |
| Web | https://www.knowlabs.co |
Phillip Bosua Latest Insider Activity
Tracking and analyzing the buying and selling activities of Phillip Bosua against Know Labs stock is an integral part of due diligence when investing in Know Labs. Phillip Bosua insider activity provides valuable insight into whether Know Labs is net buyers or sellers over its current business cycle. Note, Know Labs insiders must abide by specific rules, including filing SEC forms every time they buy or sell Know Labs'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Phillip Bosua over six months ago Disposition of 975000 shares by Phillip Bosua of Know Labs at 2.09 subject to Rule 16b-3 |
Know Labs Management Efficiency
The company has Return on Asset of (2.5016) % which means that on every $100 spent on assets, it lost $2.5016. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (18.6731) %, meaning that it generated no profit with money invested by stockholders. Know Labs' management efficiency ratios could be used to measure how well Know Labs manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Know Labs' Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 8.07 in 2024, whereas Return On Tangible Assets are likely to drop (4.75) in 2024. At this time, Know Labs' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 848.8 K in 2024, whereas Other Current Assets are likely to drop 5,502 in 2024.Similar Executives
| Found 10 records | INSIDER Age | ||
| Guy Wagner | Wearable Devices | 46 | |
| Soojae Cho | Yoshiharu Global Co | 55 | |
| Alon CPA | Wearable Devices | 57 | |
| Leeor Langer | Wearable Devices | 42 | |
| Xiaolei Ni | Jianzhi Education Technology | 38 | |
| Maria JD | bioAffinity Technologies, | 68 | |
| Asher Dahan | Wearable Devices | 46 | |
| Masahiro Yamamoto | Wearable Devices | N/A | |
| Yong Hu | Jianzhi Education Technology | 47 | |
| Xavier MS | bioAffinity Technologies, | 54 | |
Management Performance
| Return On Equity | -18.67 | ||||
| Return On Asset | -2.5 |
Know Labs Leadership Team
Elected by the shareholders, the Know Labs' board of directors comprises two types of representatives: Know Labs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Know. The board's role is to monitor Know Labs' management team and ensure that shareholders' interests are well served. Know Labs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Know Labs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Phillip Bosua, CEO Director | ||
| Jessica English, Chief Officer | ||
| Peter Conley, CFO Property | ||
| Dominic Klyve, Chief Officer | ||
| MD Anderson, Scientific Medical | ||
| Steven Kent, Chief Officer | ||
| Jordyn Hujar, Chief Staff | ||
| John Cronin, Interim Director | ||
| Ronald JD, Chairman Founder | ||
| MS MBA, President International | ||
| Leonardo Trautwein, Chief Officer | ||
| Leonardo Troutwein, Chief Officer | ||
| Masanori Takee, VP Engineering |
Know Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Know Labs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -18.67 | ||||
| Return On Asset | -2.5 | ||||
| Current Valuation | 26.86 M | ||||
| Shares Outstanding | 108.1 M | ||||
| Shares Owned By Insiders | 26.05 % | ||||
| Shares Owned By Institutions | 4.83 % | ||||
| Number Of Shares Shorted | 1.3 M | ||||
| Price To Book | 47.22 X | ||||
| Price To Sales | 15.57 X | ||||
| Gross Profit | 4.36 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Know Stock Analysis
When running Know Labs' price analysis, check to measure Know Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Know Labs is operating at the current time. Most of Know Labs' value examination focuses on studying past and present price action to predict the probability of Know Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Know Labs' price. Additionally, you may evaluate how the addition of Know Labs to your portfolios can decrease your overall portfolio volatility.